Northern Trust Corp Trevena Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.2 - $0.5 $220,197 - $550,494
-1,100,988 Reduced 79.41%
285,423 $118,000
Q1 2022

May 13, 2022
SELL
$0.41 - $0.63 $43,901 - $67,457
-107,076 Reduced 7.17%
1,386,411 $762,000
Q4 2021

Feb 08, 2022
SELL
$0.57 - $1.29 $38,226 - $86,512
-67,064 Reduced 4.3%
1,493,487 $871,000
Q3 2021

Nov 15, 2021
BUY
$1.11 - $1.7 $1.09 Million - $1.66 Million
977,552 Added 167.68%
1,560,551 $1.92 Million
Q2 2021

Aug 13, 2021
BUY
$1.46 - $2.25 $429,942 - $662,582
294,481 Added 102.07%
582,999 $985,000
Q1 2021

May 12, 2021
BUY
$1.77 - $2.93 $10,294 - $17,040
5,816 Added 2.06%
288,518 $516,000
Q4 2020

Feb 11, 2021
BUY
$2.13 - $3.26 $61,322 - $93,855
28,790 Added 11.34%
282,702 $605,000
Q3 2020

Nov 16, 2020
BUY
$1.53 - $3.13 $45,610 - $93,308
29,811 Added 13.3%
253,912 $759,000
Q2 2020

Aug 14, 2020
BUY
$0.48 - $1.75 $4,802 - $17,510
10,006 Added 4.67%
224,101 $336,000
Q1 2020

May 14, 2020
BUY
$0.56 - $0.97 $32,366 - $56,063
57,797 Added 36.98%
214,095 $121,000
Q1 2019

May 13, 2019
BUY
$0.51 - $1.88 $10,501 - $38,712
20,592 Added 15.17%
156,298 $244,000
Q4 2018

Feb 12, 2019
SELL
$0.39 - $3.47 $5,434 - $48,350
-13,934 Reduced 9.31%
135,706 $59,000
Q3 2018

Nov 14, 2018
BUY
$1.39 - $2.25 $43,507 - $70,425
31,300 Added 26.45%
149,640 $317,000
Q2 2018

Aug 14, 2018
SELL
$1.44 - $2.24 $664,354 - $1.03 Million
-461,357 Reduced 79.59%
118,340 $170,000
Q1 2018

May 09, 2018
BUY
$1.51 - $2.06 $54,310 - $74,092
35,967 Added 6.61%
579,697 $950,000
Q4 2017

Feb 14, 2018
BUY
$1.4 - $2.6 $1,596 - $2,964
1,140 Added 0.21%
543,730 $870,000
Q3 2017

Nov 13, 2017
BUY
$2.22 - $2.79 $1.2 Million - $1.51 Million
542,590
542,590 $1.38 Million

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email